Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 319.42
+2.42 (0.76%)
Jul 29, 2025, 4:10 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 20.89 billion as of July 29, 2025. Its market cap has decreased by -4.46% in one year.
Market Cap
20.89B
Enterprise Value
20.75B
Revenue
2.31B
Ranking
n/a
PE Ratio
56.62
Stock Price
319.42
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 20.89B, an increase of 47,182.68%. That is a compound annual growth rate of 23.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 20.73B | 9.30% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | 12.43B | -4.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 129.73B |
| Pro Medicus | 33.52B |
| Sonic Healthcare | 13.87B |
| Ramsay Health Care | 8.87B |
| Telix Pharmaceuticals | 7.19B |
| Ansell | 4.48B |
| Mesoblast | 3.22B |
| Regis Healthcare | 2.40B |